These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6754)

  • 1. Effects of alpha-methyldopa on blood pressure in the anaesthetized dog.
    Blower PR; Poyser RH; Robertson MI
    J Pharm Pharmacol; 1976 May; 28(5):437-40. PubMed ID: 6754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of central and peripheral mechanisms in the action of alpha-methyldopa on blood pressure and renin secretion.
    Frankel RJ; Reid IA; Ganong WF
    J Pharmacol Exp Ther; 1977 May; 201(2):400-5. PubMed ID: 323462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further evidence for a central hypotensive action of alpha-methyldopa in both the rat and cat.
    Finch L; Haeusler G
    Br J Pharmacol; 1973 Feb; 47(2):217-28. PubMed ID: 4722038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic disposition and cardiovascular effects of methyldopate in unanesthetized rhesus monkeys.
    Walson PD; Marshall KS; Forsyth RP; Rapoport R; Melmon KL; Castagnoli N
    J Pharmacol Exp Ther; 1975 Oct; 195(1):151-8. PubMed ID: 810574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The central component of the blood pressure lowering effect of alpha-methyldopa in cats].
    Henning M; van Zwieten PA
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 260(2):140-1. PubMed ID: 4239179
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma concentration of alpha-methyldopa and sulphate conjugate after oral administration of methyldopa and intravenous administration of methyldopa and methyldopa hydrochloride ethyl ester.
    Saavedra JA; Reid JL; Jordan W; Rawlins MD; Dollery CT
    Eur J Clin Pharmacol; 1975 Aug; 8(6):381-6. PubMed ID: 1233238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of effect of alpha-methyldopa on pressor reflexes.
    Montastruc P; Sinues-Porta B
    J Pharmacol; 1983; 14(4):405-11. PubMed ID: 6672463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central hypotensive action of alpha-methyldopa: an iontophoretic study in the cat.
    Sharma JN; Sandrew BB; Wang SC
    Arch Int Pharmacodyn Ther; 1979 Sep; 241(1):92-9. PubMed ID: 526073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypotensive activity of S-alpha-methyldopa during long-term (steady-state) intravenous infusions.
    Walson PD; Pesout J; Forsyth RP; Castagnoli N; Melmon KL
    J Pharmacokinet Biopharm; 1976 Oct; 4(5):389-94. PubMed ID: 826619
    [No Abstract]   [Full Text] [Related]  

  • 10. Modification of the central hypotensive effect of alpha-methyldopa by reserpine, imipramine and tranylcypromine.
    Kale AK; Satoskar RS
    Eur J Pharmacol; 1970 Jan; 9(1):120-3. PubMed ID: 5434287
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of methyldopa treatment on peripheral sympathetic nerve function in the dog.
    Lokhandwala MF; Buckley JP; Jandhyala BS
    Eur J Pharmacol; 1975; 32(02):170-8. PubMed ID: 1097259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of action of methyldopa in the rat. Role of 3-O-methylated metabolites.
    Zavisca FG; Breau AP; Wurtman RJ
    Circ Res; 1979 Nov; 45(5):684-90. PubMed ID: 487531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of the hypotensive action of methyldopa in normal and immunosympathectomized rats.
    Ayitey-Smith E; Varma DR
    Br J Pharmacol; 1970 Oct; 40(2):186-93. PubMed ID: 5492891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A correlation between the hypotensive action of methyldopa and its depression of peripheral sympathetic function.
    Salmon GK; Ireson JD
    Arch Int Pharmacodyn Ther; 1970 Jan; 183(1):60-4. PubMed ID: 5437326
    [No Abstract]   [Full Text] [Related]  

  • 15. Further evidence for a central hypotensive action of -methyldopa.
    Finch L; Haeusler G
    Br J Pharmacol; 1972 May; 45(1):167P-168P. PubMed ID: 5041484
    [No Abstract]   [Full Text] [Related]  

  • 16. Central inhibitory effect of alpha-methyldopa on blood pressure, heart rate and body temperature of renal hypertensive rats.
    Nijkamp FP; Ezer J; De Jong W
    Eur J Pharmacol; 1975 Apr; 31(2):243-9. PubMed ID: 1149791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site of action of methyldopa in lowering the blood pressure in man.
    Kersting F; Reid JL; Dollery CT
    Clin Exp Pharmacol Physiol Suppl; 1978; 4():11-5. PubMed ID: 277299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further studies on the mechanism of the central hypotensive effect of L-dopa, DL-m-tyrosine and L-alpha-methyldopa.
    Rubenson A
    J Pharm Pharmacol; 1971 Mar; 23(3):228-30. PubMed ID: 4396899
    [No Abstract]   [Full Text] [Related]  

  • 19. Possible involvement of beta endorphin(1-31) and dynorphin(1-13) in the central hypotensive mechanism of action of alpha methyldopa.
    van Giersbergen PL; Wiegant VM; de Jong W
    Neuroendocrinology; 1989 Jan; 49(1):71-9. PubMed ID: 2566129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central hypotensive effect of alpha-methyldopa.
    Henning M; van Zwieten PA
    Acta Pharmacol Toxicol (Copenh); 1967; 25():Suppl 4:25. PubMed ID: 5630931
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.